Generic filters
Exact matches only
Search in title
Search in content
Search in excerpt

Scientific Posters and Presentations

Home / Resources / Scientific Posters and Presentations
QPS-logo-white-tagline

  • Enter Keyword

  • Year

February 7, 2022 - February 11, 2022 | San Diego, CA & Virtual Event
CHARACTERIZATION OF IN VIVO AND IN VITRO DRUG SCREENING MODELS FOR GAUCHER DISEASE BASED ON GBA-D409V-KI MICE

Tina Loeffler, Breznik Livia, Ewald Auer, Irene Schilcher, Birgit Hutter-Paier, Manuela Prokesch

Tina Loeffler, PhD will present the abstract during a moderated poster session on Thursday, February 10, 2022 from 3:00-5:00 PM (PST)

QPS Austria GmbH, Parkring 12, 8074 Grambach, Austria
BEHAVIORAL CHARACTERIZATION OF HOMOZYGOUS 6NEO MICE AS MODEL OF POMPE DISEASE

Livia Breznik, Spyridon Sideromenos, Agnes Molnar-Kasza, Roland Rabl, Stefanie Flunkert, Manuela Prokesch, Birgit Hutter-Paier

Livia Breznik, MSc will present the abstract during a moderated poster session on Thursday, February 10, 2022 from 3:00-5:00 PM (PST)

QPS Austria GmbH, Parkring 12, 8074 Grambach, Austria
September 28, 2021 - September 30, 2021 | Salzburg, Austria
BEHAVIOURAL CHARACTERIZATION OF THE FMR1 KNOCK-OUT MOUSE MODEL OF AUTISM SPECTRUM DISORDER (ASD)

Shirin Sharghi1,2, Magdalena Daurer1, Stefanie Flunkert1, Boris Philippe Chagnaud2, Marcello Leopoldo3, Enza Lacivita3 and Birgit Hutter-Paier1

1Department of Neuropharmacology, QPS Austria GmbH, Grambach, Austria, 2Institute for Biology, Karl-Franzens University of Graz, Graz, Austria, 3Department of Pharmacy-Drug Sciences, University of Bari, Bari, Italy
November 24, 2021 - November 26, 2021 | Barcelona, Spain
THE DEVELOPMENT OF A HYBRIDIZATION ECLIA ASSAY FOR THE DETERMINATION OF THE PAYLOAD OF A OLIGONUCLEOTIDE-ANTIBODY CONJUGATE

Niels Nijstad, PhD

Niels Nijstad, PhD will be making a presentation on Day 1 – Wednesday 24th Nov. 2021 14:40 - 15:00.

July 26, 2021 - July 30, 2021 | Denver, USA and Virtual Event
ASTAXANTHIN ENHANCES LRP1-MODULATED INSULIN SENSITIVITY AND AMYLOID BETA CLEARANCE IN AN IN VITRO BLOOD-BRAIN BARRIER MODEL

Joshua Adekunle Babalola1,2,3, Magdalena Lang2, Meekha George2, Anika Stracke2, Jelena Tadic4, Frank Madeo4, Achim Lass4, Gerd Leitinger5, Birgit Hutter-Paier3, Gerald Hoefler1 and Ute Panzenboeck2

1Diagnostic and Research Institute of Pathology, Medical University of Graz, Austria, 2Division of Immunology and Pathophysiology, Otto Loewi Research Center, Medical University of Graz, Austria; 3QPS Austria GmbH, Department Neuropharmacology; 4Institute of Molecular Biosciences, University of Graz, Graz, Austria; 5Division of Cell Biology, Histology and Embryology, Gottfried Schatz Research Center, Medical University of Graz, Austria.
June 4, 2021 - June 6, 2021 | Virtual Event
BTBR T+ Itpr3tf/J MICE, A SUITABLE ANIMAL MODEL TO STUDY ANXIETY AND REPETITIVE BEHAVIORS IN AUTISM SPECTRUM DISORDER

Shirin Sharghi1,2, Magdalena Daurer1, Stefanie Flunkert1, Boris Philippe Chagnaud2, Marcello Leopoldo3, Enza Lacivita3 and Birgit Hutter-Paier1

1Department of Neuropharmacology, QPS Austria GmbH, Grambach, Austria; 2Institute for Biology, Karl-Franzens University of Graz, Graz, Austria; 3Department of Pharmacy, Drug Sciences, University of Bari, Bari, Italy
March 9, 2021 - March 14, 2021 | Virtual Event
A53T-MUTATED HUMAN Α-SYNUCLEIN IS INVOLVED IN BLOOD GLUCOSE REGULATION OF WESTERN TYPE DIET-FED PARKINSON’S DISEASE MICE

Magdalena Daurer1,2, Roland Rabl1, Heinrich Roemer2, Birgit Hutter-Paier1

1QPS Austria GmbH, Grambach, Austria ;2Karl-Franzens University of Graz, Institute of Zoology, Austria
IN VITRO AND IN VIVO MODELING OF MUTATED A53T ALPHA-SYNUCLEIN PATHOLOGY

Tina Loeffler, Roland Rabl, Irene Schilcher, Magdalena Daurer, Stefanie Flunkert, Birgit Hutter-Paier

QPS Austria GmbH, Parkring 12, 8074 Grambach, Austria
REPURPOSING OF THE ANTI-ASTHMATIC DRUG MONTELUKAST FOR THE TREATMENT OF PARKINSON’S DISEASE

Katharina Strempfl1,2,3, Michael S. Unger2,3, Ludwig Aigner2,3, Jörg Neddens1, Stefanie Flunkert1, Birgit Hutter-Paier1

1QPS Austria GmbH, Neuropharmacology, Grambach, Austria; 2Institute of Molecular Regenerative Medicine, Paracelsus Medical University, Salzburg, Austria; 3Spinal Cord Injury and Tissue Regeneration Center Salzburg (SCI-TReCS), Paracelsus Medical University, Salzburg, Austria
COMPARISON OF TWO DIFFERENT IN VITRO MODELS OF NEUROINFLAMMATION: CYTOKINE RELEASE AND INFLAMMASOME ACTIVATION IN ORGANOTYPIC SLICES AND BV2 CELLS

Irene Schilcher, Tina Loeffler, Stefanie Flunkert, Birgit Hutter-Paier

QPS Austria GmbH, Parkring 12, 8074 Grambach, Austria
TREATMENT OF APPSL TRANSGENIC MICE WITH AN ALDH2 ACTIVATOR AS A PROMISING TREATMENT OPTION FOR ALZHEIMER’S DISEASE

Barbara Hinteregger1,2, Stefanie Flunkert1, Tobias Madl2, Joerg Neddens1, Wenjin Yang3 and Birgit Hutter-Paier1

1QPS Austria GmbH, Neuropharmacology, Grambach, Austria, 2Gottfried Schatz Research Center (for Cell Signaling, Metabolism and Aging), Division of Molecular Biology and Biochemistry, Medical University of Graz, Graz, Austria, 3Foresee Pharmaceuticals Co., Ltd., Taipei, Taiwan

Time is of the essence in Drug Development.

Contact the QPS Business Development Team Today!

Your link to a rewarding career.

Join the QPS team and be part of our growing organization.

Submit Your Resume

About qps

Preclinical Services

Clinical Services

Resources

Headquarters Location

Delaware Technology Park,
3 Innovation Way,
Newark, DE 19711

Connect with us

Linkedin-in Youtube Facebook-f Instagram
download-ios
download-google
qps-assay-finder-black
Copyright © 2024 · QPS Holdings. All Rights Reserved
Scroll to Top